The erectile dysfunction devices market is estimated to be valued at US$ 1.55 Bn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Erectile dysfunction devices are medical devices used to treat erectile dysfunction in males. These devices help achieve an erection by using either penile injection therapy or penile pumps. Penile injection therapy uses medicines that are injected directly into the side of the penis to achieve erection. Whereas, penile pumps are composed of a pump, cylinder, pressure-regulating valve, and constriction ring. The pump helps drawing blood into the penis to achieve erection. The cylinder and constriction ring help maintain the erection.
Market Dynamics:
The increasing prevalence of erectile dysfunction around the globe is a major factor driving the growth of the erectile dysfunction devices market. As per the projections of Massachusetts Male Aging Study, around 5% of men suffer from erectile dysfunction between ages 40 to 69 and around 15% of men suffer from it between ages 70 and 79. The rising healthcare expenditure and investments from key players to develop advanced devices are further fueling the market growth. Moreover, the growing awareness about available treatment options for erectile dysfunction is boosting the adoption of ED devices. However, risks and limitations associated with these ED treatments such as bruising or bleeding at injection sites in case of penile injections and pain in case of penile pumps may hamper the market growth over the forecast period.
SWOT Analysis
Strength: Erectile Dysfunction Devices Market Size has three main strengths. It has a large patient pool suffering from erectile dysfunction. There is a rising awareness about treatment options available for erectile dysfunction. Non-invasive nature of devices is preferred over pharmacological therapies.
Weakness: Lack of medical reimbursement and high cost of devices in some countries is a major challenge. Devices require proper knowledge to use which can lead to complications if not used correctly.
Opportunity: Growing geriatric population suffering from erectile dysfunction presents lucrative growth opportunities. Advancements in design and performance of devices is expanding their applications.
Threats: Strong competition from generic drugs manufacturing can capture market share of devices. Shift towards herbal drugs and alternative therapies pose threat to devices.
Key Takeaways:
The global Erectile Dysfunction Devices market is expected to witness high growth, exhibiting CAGR of 9.5% over the forecast period, due to increasing erectile dysfunction prevalence primarily driven by rising obesity rates, sedentary lifestyles, and chronic diseases.
Regional analysis: North America holds leading share in the erectile dysfunction devices market attributed to growing adoption of devices and presence of key manufacturers. Asia Pacific market is expected to witness fastest growth owing to rise in ageing population, increase in health awareness and availability of devices at affordable prices.
Key players operating in the Erectile Dysfunction Devices market are Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, Silimed, Giddy, Alma Lasers, and Futura Medical plc. The major players are focusing on launching new innovative and user-friendly devices to strengthen their market position.
Read Our More Blogs : https://www.pressreleasebulletin.com/erectile-dysfunction-devices-market-analysis-growth-forecast-outlook-2023-2030/
Sign in to leave a comment.